Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

1,019 Results (Page 22 of 51)
- Relevance
  Sort by

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
March 2023
161 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
April 2023
1369 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Diffuse Large B-cell Lymphoma (DLBCL) Therapeutics Market 2025-2029

 Report
May 2025
220 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Red Biotechnology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
115 Pages
Global

From

€4252EUR$4,750USD£3,714GBP

Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
May 2023
171 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pulmonary Arterial Hypertension Medicine Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2022
83 Pages
Global

From

€3500EUR$4,189USD£3,164GBP

Pulmonary Arterial Hypertension (PAH) - Global Strategic Business Report

 Report
April 2026
150 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Colorectal Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

 Report
July 2024
190 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Metastatic Colorectal Cancer - Pipeline Insight, 2025

 Drug Pipelines
April 2025
280 Pages
Global

From

€2685EUR$3,000USD£2,346GBP

Generic Pharmaceuticals Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Pediatric Medicines - Global Strategic Business Report

 Report
April 2026
387 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Basal Cell Carcinoma Treatment Market - Global Forecast 2026-2032

 Report
January 2026
193 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Global Pediatric Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
119 Pages
Global

From

€4252EUR$4,750USD£3,714GBP

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

 Report
August 2018
340 Pages
Global

From

€3132EUR$3,499USD£2,736GBP

Antimicrobial Therapeutics Market - Global Strategic Business Report

 Report
March 2026
494 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Mitoxantrone Hydrochloride Market - Global Forecast to 2030

 Report
August 2025
187 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Collaboration Deals in Pharmaceuticals 2020-2026

 Report
March 2026
850 Pages
Global

From

€4471EUR$4,995USD£3,906GBP

Licensing Deals in Pharmaceuticals 2020-2026

 Report
March 2026
1200 Pages
Global

From

€4471EUR$4,995USD£3,906GBP

Prostate Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

1,019 Results (Page 22 of 51)
- 1
- 20
- 21
- 22
- 23
- 24

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.